Wednesday, September 11, 2024
wellness India Expo
Home Tags Cancer treatment

Tag: cancer treatment

Immuneel Therapeutics appoints Amit Mookim as CEO

The former IQVIA South Asia Managing Director will lead Immuneel’s mission of expanding access to cutting-edge cancer treatments globally

Antidepressant Selegiline shows promise as cost-effective breast cancer treatment

Guwahati researchers at IASST repurpose Selegiline for potential breast cancer therapy through innovative drug repurposing strategies

Medanta hosts 14th Annual Indian Brachytherapy Society Conference in Gurugram

Top brachytherapy experts and oncologists gathered at Medanta for a comprehensive discussion on advancements in cancer treatment

University of Leeds scientists develop nanosurgical tool to combat cancer

Innovative nanopipette, 500 times thinner than a human hair, could provide unprecedented real-time insights into cancer treatment resistance

4baseCare welcomes tech visionary Lip-Bu Tan to Advisory Board

Venture capitalist Lip-Bu Tan joins 4baseCare to advance precision oncology and bridge critical genomics data gaps

C-Care and Healthcare Global Enterprises collaborate to enhance cancer care in...

The partnership focuses on enhanced cancer care quality and accessibility through advanced clinical services, training, and patient referrals

Surgeons advocate for RAS amidst alarming rise in gynecological cancers among...

Leading surgeons highlight the urgency of adopting robotic-assisted surgery to enhance cancer treatment and improve accessibility

Sahyadri Hospitals introduces Asia’s first Radixact X9 system with VitalHold technology

New AI-powered radiotherapy system enhances precision and efficiency in cancer treatment, ensuring better patient outcomes

New study reveals key role of Kindlins in cancer treatment pathways

Research highlights potential for innovative mechano-modulatory therapeutics, offering new avenues for tumor progression and chemoresistance

Nimotuzumab boosts survival rates in head & neck cancer: Tata Memorial...

Phase III study shows significant improvement in 10-year survival rates with Nimotuzumab addition, offering new hope for patients